Cell wounding activates phospholipase D in primary mouse keratinocytes

Journal of Lipid Research

Volumn 54, Issue 3, 2013, Pages 581-591

  Arun, Senthil N ^a   Xie, Ding ^c   Howard, Amber C ^d   Zhong, Quincy ^c   Zhong, Xiaofeng ^c   McNeil, Paul L ^d   Bollag, Wendy B ^a,b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Institute of Molecular Medicine and Genetics   (United States)

^c Department of Physiology ^*  (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

5 fl uoro 2 indolyl des chlorohalopemide; Aquaporin 3; Phosphatidylglycerol; Skin; Wound healing

Indexed keywords

AQUAPORIN 3; CALCITRIOL; ENZYME INHIBITOR; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPASE D; PHOSPHOLIPASE D INHIBITOR; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL WOUNDING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; IN VIVO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SKIN INJURY; WOUND HEALING;

ANIMALS; AQUAPORIN 3; CALCITRIOL; CELLS, CULTURED; ENZYME ACTIVATION; FEMALE; KERATINOCYTES; MALE; MICE; PHOSPHATIDYLGLYCEROLS; PHOSPHOLIPASE D; WOUND HEALING;

EID: 84874033455     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M027060     Document Type: Article

References (44)

1. Bollag, W. B., M. E. Dodd, and B. A. Shapiro. 2004. Protein kinase D and keratinocyte proliferation. Drug News Perspect. 17 : 117-126.
2. Chamcheu, J. C., I. A. Siddiqui, D. N. Syed, V. M. Adhami, M. Liovic, and H. Mukhtar. 2011. Keratin gene mutations in disorders of human skin and its appendages. Arch. Biochem. Biophys. 508 : 123-137.
3. McNeil, P. L., and T. Kirchhausen. 2005. An emergency response team for membrane repair. Nat. Rev. Mol. Cell Biol. 6 : 499-505.
4. Miyake, K., T. Tanaka, and P. L. McNeil. 2006. Disruption-induced mucus secretion: repair and protection. PLoS Biol. 4 : e276.
5. McNeil, P. L., and S. Ito. 1989. Gastrointestinal cell plasma membrane wounding and resealing in vivo. Gastroenterology. 96 : 1238-1248.
6. Miyake, K., T. Tanaka, and P. L. McNeil. 2007. Lectin-based food poisoning a new mechanism of protein toxicity. PLoS ONE .2 : e687.
7. McNeil, P. L., and R. Khakee. 1992. Disruptions of muscle fi ber plasma membrane. Role in exercise-induced damage. Am. J. Pathol. 140 : 1097-1109.
8. McNeil, P. L., and S. Ito. 1990. Molecular traffi c through plasma membrane disruptions of cells in vivo. J. Cell Sci. 96 : 549-556.
9. Bansal, D., K. Miyake, S. S. Vogel, S. Groh, C. C. Chen, R. Williamson, P. L. McNeil, and K. P. Campbell. 2003. Defective membrane repair in dysferlin-defi cient muscular dystrophy. Nature. 423 : 168-172.
10. Jaiswal, J. K., G. Marlow, G. Summerill, I. Mahjneh, S. Mueller, M. Hill, K. Miyake, H. Haase, L. V. Anderson, I. Richard, et al. 2007. Patients with a non-dysferlin Miyoshi myopathy have a novel membrane repair defect. Traffi c. 8 : 77-88.
11. Gomez-Cambronero, J. 2010. New concepts in phospholipase D signaling in infl ammation and cancer. Scientifi cWorldJournal. 10 : 1356-1369.
12. Liscovitch, M., M. Czarney, G. Fiucci, and X. Tang. 2000. Phospholipase D: molecular and cell biology of a novel gene family. Biochem. J. 345 : 401-415.
13. Bollag, W. B., and X. Zheng. 2005. Phospholipase D and keratinocyte biology. In Trends in Protein Research. J. W. Robinson, editor. Nova Science Publishers, Inc., New York. 79-118.
14. Qin, H., X. Zheng, X. Zhong, A. K. Shetty, P. M. Elias, and W. B. Bollag. 2011. Aquaporin-3 in keratinocytes and skin: its role and interaction with phospholipase D2. Arch. Biochem. Biophys. 508 : 138-143.
15. Zheng, X., and W. Bollinger Bollag. 2003. Aquaporin 3 colocates with phospholipase d2 in caveolin-rich membrane microdomains and is downregulated upon keratinocyte differentiation. J. Invest. Dermatol. 121 : 1487-1495.
16. Zheng, X., S. Ray, and W. B. Bollag. 2003. Modulation of phospholipase D-mediated phosphatidylglycerol formation by differentiating agents in primary mouse epidermal keratinocytes. Biochim. Biophys. Acta. 1643 : 25-36.
17. Bollag, W. B., D. Xie, X. Zheng, and X. Zhong. 2007. A potential role for the phospholipase D2-aquaporin-3 signaling module in early keratinocyte differentiation: production of a phosphatidylglycerol signaling lipid. J. Invest. Dermatol. 127: 2823-2831.
18. Riebeling, C., A. J. Morris, and D. Shields. 2009. Phospholipase D in the Golgi apparatus. Biochim. Biophys. Acta. 1791 : 876-880.
19. Griner, R. D., F. Qin, E. M. Jung, C. K. Sue-Ling, K. B. Crawford, R. Mann-Blakeney, R. J. Bollag, and W. B. Bollag. 1999. 1,25-Dihydroxyvitamin D3 induces phospholipase D-1 expression in primary mouse epidermal keratinocytes. J. Biol. Chem. 274 : 4663-4670.
20. Howard, A. C., A. K. McNeil, and P. L. McNeil. 2011. Promotion of plasma membrane repair by vitamin E. Nat. Commun. 2 : 597.
21. Howard, A. C., A. K. McNeil, F. Xiong, W. C. Xiong, and P. L. McNeil. 2011. A novel cellular defect in diabetes: membrane repair failure. Diabetes. 60 : 3034-3043.
22. Muthukrishnan, L., E. Warder, and P. L. McNeil. 1991. Basic fi broblast growth factor is effi ciently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J. Cell. Physiol. 148 : 1-16.
23. Bollag, W. B., and R. J. Bollag. 2001. 1,25-Dihydroxyvitamin D3, phospholipase D and protein kinase C in keratinocyte differentiation. Mol. Cell. Endocrinol. 177 : 173-182.
24. Scott, S. A., P. E. Selvy, J. R. Buck, H. P. Cho, T. L. Criswell, A. L. Thomas, M. D. Armstrong, C. L. Arteaga, C. W. Lindsley, and H. A. Brown. 2009. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat. Chem. Biol. 5 : 108-117
25. Zheng, X., and W. B. Bollag. 2003. Aquaporin 3 colocates with phospholipase D2 in caveolin-rich membrane microdomains and is regulated by keratinocyte differentiation. J. Invest. Dermatol. 121 : 1487-1495.
26. Su, W., O. Yeku, S. Olepu, A. Genna, J. S. Park, H. Ren, G. Du, M. H. Gelb, A. J. Morris, and M. A. Frohman. 2009. 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol. Pharmacol. 75 : 437-446.
27. Jung, E. M., S. Betancourt-Calle, R. Mann-Blakeney, R. D. Griner, and W. B. Bollag. 1999. Sustained phospholipase D activation is associated with keratinocyte differentiation. Carcinogenesis. 20 : 569-576.
28. Goldsmith, L. A. 2013. Clinical snippets. J. Invest. Dermatol. 133 : 4.
29. Divecha, N., M. Roefs, J. R. Halstead, S. D'Andrea, M. Fernandez-Borga, L. Oomen, K. M. Saqib, M. J. O. Wakelam, and C. D'Santos. 2000. Interaction of the type I PIPkinase with phospholipase D: a role for the local generation of phosphatidylinositol 4,5-bisphosphate in the regulation of PLD2 activity. EMBO J. 19 : 5440-5449.
30. Oude Weernick, P. A., M. Lopez de Jesus, and M. Schmidt. 2007. Phospholipase D signaling: orchestration by PIP2 and small GTPases. Naunyn Schmiedebergs Arch. Pharmacol. 374 : 399-411.
31. Tang, W., V. A. Ziboh, R. R. Isseroff, and D. Martinez. 1987. Novel regulatory actions of 1a,25-dihydroxyvitamin D3 on the metabolism of polyphosphoinositides in murine epidermal keratinocytes. J. Cell. Physiol. 132 : 131-136.
32. Pillai, S., D. D. Bikle, M-J. Su, A. Ratnam, and J. Abe. 1995. 1,25-Dihydroxyvitamin D3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels. J. Clin. Invest. 96 : 602-609.
33. Du, G., P. Huang, B. T. Liang, and M. A. Frohman. 2004. Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol. Biol. Cell. 15: 1024-1030.
34. Freyberg, Z., D. Sweeney, A. Siddhanta, S. Bourgoin, M. Frohman, and D. Shields. 2001. Intracellular localization of phospholipase D1 in mammalian cells. Mol. Biol. Cell. 12 : 943-955.
35. Frohman, M. A., and A. J. Morris. 1996. Rho is only ARF the story. Phospholipid signaling. Curr. Biol. 6 : 945-947.
36. Hara, M., T. Ma, and A. S. Verkman. 2002. Selectively reduced glycerol in skin of aquaporin-3-defi cient mice may account for impaired skin hydration, elasticity, and barrier recovery. J. Biol. Chem. 277 : 46616-46621.
37. Hara, M., and A. S. Verkman. 2003. Glycerol replacement corrects defective skin hydration, elasticity, and barrier function in aquaporin-3-defi cient mice. Proc. Natl. Acad. Sci. USA. 100 : 7360-7365.
38. Cao, C., Y. Sun, S. Healey, Z. Bi, G. Hu, S. Wan, N. Kouttab, W. Chu, and Y. Wan. 2006. EGFR-mediated expression of aquaporin-3 is involved in human skin fi broblast migration. Biochem. J. 400 : 225-234.
39. Marchini, G., B. Stabi, K. Kankes, S. Lonne-Rahm, M. Ostergaard, and S. Nielsen. 2003. AQP1 and AQP3, psoriasin, and nitric oxide synthases 1-2 are infl ammatory mediators in erythema toxicum neonatorum. Pediatr. Dermatol. 20 : 377-384.
40. Zhu, N., X. Feng, C. He, H. Gao, L. Yang, Q. Ma, L. Guo, Y. Qiao, H. Yang, and T. Ma. 2011. Defective macrophage function in aquaporin-3 defi ciency. FASEB J. 25 : 4233-4239.
41. Zucker, P. F., A. M. Chan, and M. C. Archer. 1986. Cellular toxicity of pancreatic carcinogens. J. Natl. Cancer Inst. 76 : 1123-1127.
42. Flint, O. P., B. A. Masters, R. E. Gregg, and S. K. Durham. 1997. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro. Toxicol. Appl. Pharmacol. 145 : 91-98.
43. Barile, F. A., S. Arjun, and D. Hopkinson. 1993. In vitro cytotoxicity testing: biological and statistical signifi cance. Toxicol. In Vitro. 7 : 111-116.
44. Bansal, D., and K. P. Campbell. 2004. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol. 14 : 206-213.